Durability in cancer treatment is the measure of how long a treatment can effectively control or eradicate cancer without the disease returning or worsening. This concept is particularly significant in immunotherapy and targeted therapy, where the duration of response can vary greatly among patients. Durable responses are often indicative of a more successful long-term treatment outcome.
